Nanocarriers and their Integrated Microneedle Systems-Mediated Drug Delivery for the Treatment of Moderate-Severe Dermatological Diseases: Recent Progress, Applications and Future Perspectives
Journal of Drug Delivery Science and Technology,
Год журнала:
2025,
Номер
106, С. 106748 - 106748
Опубликована: Фев. 22, 2025
Язык: Английский
Novel strategies in topical delivery for psoriasis treatment: nanocarriers and energy-driven approaches
Expert Opinion on Drug Delivery,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 25, 2025
Psoriasis
is
characterized
by
abnormal
differentiation
and
hyperproliferation
of
epidermal
keratinocytes.
This
condition
presents
significant
challenges
for
effective
drug
delivery.
In
addition
to
overcoming
the
thickness
skin,
topical
treatments
must
navigate
complex
hydrophobic
hydrophilic
properties
skin
barrier.
Recent
advancements
in
nanocarrier
technologies,
including
energy-driven
methods
microneedles
that
penetrate
stratum
corneum,
present
promising
strategies
enhancing
permeation
through
tailored
physicochemical
properties.
A
literature
search
was
performed
using
databases
Google
Scholar,
PubMed,
ScienceDirect.
review
highlights
recent
studies
on
novel
delivery
psoriasis
treatment,
addressing
current
therapeutic
options
their
limitations.
We
provide
a
comprehensive
overview
chemical
nanoformulations
explore
physical
improve
rates.
Furthermore,
we
discuss
advantages
various
formulations
can
carry
different
types
payloads,
offering
patients
diverse
symptom
management.
The
covers
conventional
treatments,
emphasizing
nanoparticle
design
macromolecular
drugs.
includes
Ribonucleic
acid
(RNA)-based
therapies
protect
drugs
from
rapid
clearance
body.
argue
intelligent
approaches
enhance
efficacy
across
applications
while
allowing
precision
treatment
strategies,
ultimately
improving
patient
outcomes.
Язык: Английский
The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
Pharmaceutics,
Год журнала:
2025,
Номер
17(4), С. 513 - 513
Опубликована: Апрель 14, 2025
Background/Objectives:
The
accurate
prediction
of
drug
release
profiles
from
Poly
(lactic-co-glycolic
acid)
(PLGA)-based
delivery
systems
is
a
critical
challenge
in
pharmaceutical
research.
Traditional
methods,
such
as
the
Korsmeyer-Peppas
and
Weibull
models,
have
been
widely
used
to
describe
vitro
kinetics.
However,
these
models
are
limited
by
their
reliance
on
fixed
mathematical
forms,
which
may
not
capture
complex
nonlinear
nature
behavior
diverse
PLGA-based
systems.
Method:
In
response
limitations,
we
propose
novel
approach—DrugNet,
data-driven
model
based
multilayer
perceptron
(MLP)
neural
network,
aiming
predict
data
at
unknown
time
points
fitting
curves
using
key
physicochemical
characteristics
PLGA
carriers
molecules,
well
data.
We
establish
dataset
through
literature
review,
trained
validated
determine
its
effectiveness
predicting
different
curves.
Results:
Compared
traditional
Korsmeyer–Peppas
semi-empirical
MSE
DrugNet
decreases
20.994
1.561,
respectively,
(R2)
increases
0.036
0.005.
Conclusions:
These
results
demonstrate
that
has
stronger
ability
fit
better
relationships
It
can
deal
with
change
better,
adaptability
advantages
than
overcomes
limitations
expressions
models.
Язык: Английский